US 2022/0387438 A1Published application

Calcineurin inhibitors of the setron family for the treatment of hearing loss

AssigneeSensorion

InventorJonas DYHRFJELD-JOHNSEN

Life of this patent

Estimating the term…

Abstract

Disclosed is an inhibitor of calcineurin of the setron family for use for treating hearing loss in a subject in need thereof.

Claims17

Dependent claims

A method for preventing hearing loss in a subject in need thereof, comprising administering to said subject an inhibitor of calcineurin of the setron family.

Dependencies are inferred from the claim text.

Facts

Application: 17/820,010Filed 16 Aug 2022
Priority: EP 15167992.518 May 2015
Published: 8 Dec 2022
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/538
1,4-Oxazines, e.g. morpholine: ortho- or peri-condensed with carbocyclic ring systems
A61K 31/4178
1,3-Diazoles: not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
A61K 31/4184
1,3-Diazoles: condensed with carbocyclic rings, e.g. benzimidazoles
A61K 31/46
Having six-membered rings with one nitrogen as the only ring hetero atom: 8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine

Family

Application62/163,177Us provisional application · filed 18 May 2015
Application15/574,547Continuation · filed 16 Nov 2017
Application17/820,010Continuation
US 11,433,077 B2Related patent
US 12,702,671 B2Related patent
US 2018/0207167 A1Published application
US 2022/0387438 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results